+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Ocular Side-effects of Long-term Immunosuppressive Therapy in Recipients of Cadaver Kidney Transplants

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          A report of the ophthalmologic survey of 28 bilaterally nephrectomized patients with an unilateral cadaver kidney transplant, kept under a continuous immunosuppressive therapy for up to 48 months. Two types of cataracts are delineated and discussed: anterior subepithelial and posterior subcapsular cataracts, brought about by the corticosteroid treatment, and “Glaukomflecken” like, subepithelial spots, possibly induced by a transient failure of the kidney transplant. The relation between time, dosage, age, individual factors and the occurrence of the anterior subepithelial and the posterior subcapsular cataract are discussed.

          Related collections

          Author and article information

          Ophthalmic Res
          Ophthalmic Research
          S. Karger AG
          27 November 2009
          : 1
          : 1
          : 21-30
          Department of Ophthamology (Director: Prof.Dr. R. Witmer) and the Department of Medicine (Director: Prof. Dr. P. Frick and Prof. Dr. A. Labhart), University of Zürich, Kantonsspital Zürich
          264383 Ophthal Res 1970;1:21–30
          © 1970 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10


          Comment on this article